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Background: Engineered carbon nanotubes are currently used in many consumer and industrial products such as
paints, sunscreens, cosmetics, toiletries, electronic processes and industrial lubricants. Carbon nanotubes are among
the more widely used nanoparticles and come in two major commercial forms, single-walled carbon nanotubes
(SWCNT) and the more rigid, multi-walled carbon nanotubes (MWCNT). The low density and small size of these
particles makes respiratory exposures likely. Many of the potential health hazards have not been investigated,
including their potential for carcinogenicity. We, therefore, utilized a two stage initiation/promotion protocol to
determine whether inhaled MWCNT act as a complete carcinogen and/or promote the growth of cells with existing
DNA damage. Six week old, male, B6C3F1 mice received a single intraperitoneal (ip) injection of either the initiator
methylcholanthrene(MCA, 10 μg/g BW, i.p.), or vehicle (corn oil). One week after i.p. injections, mice were exposed
by inhalation to MWCNT (5 mg/m3, 5 hours/day, 5 days/week) or filtered air (controls) for a total of 15 days. At
17 months post-exposure, mice were euthanized and examined for lung tumor formation.
Results: Twenty-three percent of the filtered air controls, 26.5% of the MWCNT-exposed, and 51.9% of the
MCA-exposed mice, had lung bronchiolo-alveolar adenomas and lung adenocarcinomas. The average number of
tumors per mouse was 0.25, 0.81 and 0.38 respectively. By contrast, 90.5% of the mice which received MCA followed
by MWCNT had bronchiolo-alveolar adenomas and adenocarcinomas with an average of 2.9 tumors per mouse
17months after exposure. Indeed, 62% of the mice exposed to MCA followed by MWCNT had bronchiolo-alveolar
adenocarcinomas compared to 13% of the mice that received filtered air, 22% of the MCA-exposed, or 14% of the
MWCNT-exposed. Mice with early morbidity resulting in euthanasia had the highest rate of metastatic disease. Three
mice exposed to both MCA and MWCNT that were euthanized early had lung adenocarcinoma with evidence of
metastasis (5.5%). Five mice (9%) exposed to MCA and MWCNT and 1 (1.6%) exposed to MCA developed serosal
tumors morphologically consistent with sarcomatous mesotheliomas, whereas mice administered MWCNT or air
alone did not develop similar neoplasms.
Conclusions: These data demonstrate that some MWCNT exposures promote the growth and neoplastic
progression of initiated lung cells in B6C3F1 mice. In this study, the mouse MWCNT lung burden of 31.2 μg/mouse
approximates feasible human occupational exposures. Therefore, the results of this study indicate that caution
should be used to limit human exposures to MWCNT.* Correspondence: lqs1@cdc.gov
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The nanotechnology industry is a multibillion dollar
industry and is expected to reach a trillion dollars by
2015 [1]. Carbon nanotubes are long thin nanoparticles
that are composed of a single wall (SWCNT) or multiple
walls (MWCNT) of graphene sheets rolled into tubes.
MWCNT have potential applications in many consumer
and industrial settings including medical devices, batter-
ies, the automobile industry, electronic processes and
the aerospace industry [2,3]. Carbon nanotubes are light
and easily aerosolized making workplace exposure to
nanoparticles a potentially significant source of human
exposure. The material resists degradation and may
persist in the body for extended periods of time [4,5].
The respiratory tract is a likely route of exposure due to
the low density and small size of airborne nanoparticles.
Similar to inhaled asbestos fibers, MWCNT deposited in
the lungs of mice by pharyngeal aspiration or inhalation
produced histologic changes including inflammation and
fibrosis as well as hypertrophied and hyperplastic
bronchiolar and alveolar epithelial cells [4,6-8]. Add-
itional changes in some alveolar epithelial Type II cells
of MWCNT-exposed mice include cellular atypia [8].
MWCNT can reach the alveolar region, the interstitium
and the pleural space after both aspiration and inhal-
ation [8-10]. Some macrophages that contain MWCNT
particles have been observed without nuclei and with
MWCNT connecting dividing chromosomes indicating
that carbon nanotubes may be capable of inducing
errors in cell division in vivo following either aspiration
or inhalation exposure [8]. Type II cells from rodents
exposed to MWCNT been shown to have micronuclei,
indicating either a higher level of chromosome damage
or mitotic spindle disruption [11]. In vitro investigations
have demonstrated that carbon nanotubes disrupt the
cell division apparatus and induce errors in chromosome
number [11-14].
The multistage nature of cancer has been described in
liver, skin and mammary as well as lung models for
cancer [15-18]. Carcinogenic agents can act in one or all
of the stages of the neoplastic process. Initiating agents
typically cause a heritable change in DNA while tumor
promoters induce proliferation of DNA damaged cells to
form visible preneoplastic or benign clones [19]. During
the last stage of neoplastic development (progression)
malignant characteristics, karyotypic instability and frank
neoplasms appear [19]. A complete carcinogen can act
at all three stages. Cellular proliferation is a feature of the
second phase of pulmonary carcinogenesis (promotion)
[16,17]. Of interest, epithelial hyperplasia and cellular
atypia were observed in mice exposed to MWCNT in vivo
[8]. Therefore, the potential for carcinogenicity is of
particular concern. In addition, previous studies have
indicated the potential for carbon nanotubes to act duringthe progression of cells from preneoplastic and early
benign lesions to carcinoma as shown by their ability to
disrupt the mitotic spindle and induce chromosome alter-
ations [17,19]. Investigations of MWCNT carcinogenicity
have demonstrated that intraperitoneal or intrascrotal in-
jection of MWCNT results in mesotheliomas in p53 +/−
transgenic mice and Fischer rats, respectively [20,21]. The
high-dose and agglomeration of the 3 mg MWCNT
exposure used in the Takagi et al. study have been
questioned, since it resulted in a high death rate due to
gastrointestinal occlusion [22]. However, a more recent
study demonstrated the induction of mesothelioma after
intraperitoneal injection of as little as 3 μg of MWCNT in
mice [23]. Because the physical properties of MWCNT
make respiratory exposure likely during the production
and processing of commercial products and pulmonary
exposures in rodents have indicated a potential for geno-
toxicity, inflammation, cell proliferation, cellular atypia,
and migration to the pleural space in a manner similar to
other long thin fiber-like materials that are carcinogenic,
there is an urgent need to examine the potential for
cancer in an animal model following inhalation of carbon
nanotubes.
The overall objective of this study was to determine
whether inhalation of MWCNT produced lung tumors
in adult, male B6C3F1 mice using a two-stage, initiation-
promotion protocol. The B6C3F1 mouse is the strain
used by the National Toxicology Program to evaluate
chemicals for potential carcinogenicity [24]. The B6C3F1
hybrid is of intermediate susceptibility for spontaneous
lung tumor formation; however, the strain is less sensi-
tive than the sensitive/intermediate 020 and BALB/cByJ
strains [25,26]. In addition, there is a wealth of informa-
tion on the spontaneous tumor response and lifespan of
the B6C3F1 mouse strain [25,27-29]. This is the first
investigation to examine the potential carcinogenicity of
carbon nanotubes using a multi-stage carcinogenesis
model in the B6C3F1 mouse lung.
Results
Foreign material observed during histopathology
assessment
The initial MWCNT lung burden of the mice exposed to
MWCNT was determined to be 31.2 ± 0.9 μg MWCNT/
lung. Light microscopic analysis demonstrated foreign ma-
terial (presumptive MWCNT) in the lungs of all mice in
the MWCNT and MCA +MWCNT groups but not in
MCA or Air control animals 17 months following expos-
ure (Table 1). By light microscopy, the foreign material
was approximately 0.5 to 5 microns in length, finely
granular to elongated, blocked light with transmitted light
(appeared black) and had bright whitish birefringence
under polarized light (Figure 1A,B). Commonly seen in
the cytoplasm of cells at terminal bronchioles and alveolar
Table 1 Incidence of focal adenomatous hyperplasia, macrophage infiltration and foreign material in the lung by light
microscopy
Focal alveolar adenomatous hyperplasia, macrophage infiltration and foreign material observed in MWCNT–treated mice 17 months
following exposure
Air MCA MWCNT MCA +MWCNT
Number of animals/group 56 54 49 42
Number animals with positive foreign material 0 0 49* 42*
Macrophage infiltration 3 9 32* 39*
Number animals with positive for focal adenomatous alveolar hyperpasia 7 8 14* 26*
Statistical significance at *p < .0001.
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macrophages or epithelial cells lining the airways, or in
macrophages within connective tissue adjacent to airway
epithelium (Table 1). It was also present in macrophages
that formed occasional random small clusters in airwaysFigure 1 Foreign material observed by light microscopy (A)
and polarized light (B). A. The figure is a low magnification image
of MWCNT deposition in the lungs. Macrophages in alveolar spaces of
the right apical lobe of the lung contain intracytoplasmic, black,
elongate to finely granular particulate material (presumptive MWCNT).
(40x). B. Using polarized light, the low magnification image
demonstrates presumptive MWCNT are seen in macrophages in the
right apical lung lobe of mouse treated with MWCNT. The material in
the macrophages are birefringent. (40x).or alveoli, and were seen extracellularly in connective
tissue and between cells. The diagnostic term “foreign
material” was exclusively used to indicate the presumptive
test article (MWCNT).
Enhanced darkfield imaging of MWCNT
Imaging using CytoViva technology demonstrated
MWCNT fibers in the lungs of MWCNT-exposed mice
thus confirming the presence of MWCNT material
observed by light microscopic analysis in the mouse
tissues 17 months following exposure to the material.
MWCNT material was observed by light microscopy in
the interstitium of the lung (Figure 2A). With enhanced
darkfield imaging MWCNT appear as bright fibrous
structures. MWCNT were observed in alveolar tissue as
shown in Figure 2B. MWCNT were also present within
the alveolar macrophages (data not shown). In addition,
enhanced darkfield analysis demonstrated MWCNT in
the diaphragm (Figure 2C).
Hyperplasia and macrophage infiltration in the lung
Regenerative alveolar epithelial hyperplasia is a common
reaction of the murine lung to inhaled toxicants, includ-
ing particles, while primary alveolar epithelial hyperpla-
sia is believed to be a preneoplastic change . In humans,
the form of primary bronchoalveolar hyperplasia consid-
ered preneoplastic is known as atypical adenomatous
hyperplasia [30-33]. Therefore, in this paper, we have
designated foci of marked, focal alveolar epithelial
hyperplasia resembling human atypical adenomatous
hyperplasia as focal adenomatous hyperplasia. Focal
adenomatous alveolar hyperplasia was characterized by
increased numbers of crowded alveolar epithelial cells
that outlined contiguous alveolar septa in discrete,
generally random locations (Figure 3). Animals with foci
of focal adenomatous hyperplasia and macrophage infil-
tration were noted. The number of animals or incidence
of focal adenomatous alveolar epithelial hyperplasia,
macrophage infiltration, foreign material, and multifocal
adenomatous bronchiolo-alveolar hyperplasia in the ter-
minal bronchiole/alveolar duct regions were increased in
both groups exposed to MWCNT (MCA+ and MCA-).
Figure 2 Cytoviva imaging. A. The figure is an example of typical
images from light and enhanced darkfield imaging of MWCNT in
lungs and diaphragm. The light micrograph of H&E stained section
demonstrates MWCNT (black fibers) in the alveolar interstitium of a
MWCNT Air exposed animal 17 months following inhalation
exposure. This micrograph shows an example of MWCNT present
within the alveolar interstium. Light microscope image using 100x
oil immersion objective. Magnification bar is 10 microns. B. The
micrograph is an enhanced darkfield image from the lung of an
animal 17 months following exposure to MWCNT. The central area
of the micrograph shows a region of alveolar wall with numerous
MWCNT fibers present. The MWCNT are bright white due to
imaging of scattered light over a broad range of wavelengths by
this nanomaterial. Lung tissue, which does not significantly
scatter light, is brown-to-orange and airspaces are black. The
enhanced darkfield microscope image was photographed using a
100x oil immersion objective. The magnification bar is 20 microns.
C. An enhanced darkfield imagine showing MWCNT in the
diaphragm. MWCNT (indicated by the upper two arrows) are
bright white. Nuclei are brown-to-orange, muscle cells are green
and red blood cells are yellow. The parietal pleural border is
indicated by the arrow in the lower part of the figure. Enhanced
darkfield microscope image using 100x oil immersion objective.
Magnification bar is 20 microns.
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est in the MCA+MWCNT group relative to MWCNT,
MCA and Air groups (Table 1). Focal alveolar epithelial
hyperplasia was scored as marked (adenomatous) in 2%,
2%, 5%, or 27% of mice in the air, MCA, MWCNT, or
MCA+MWCNTgroups, respectively.
Incidences of macrophage infiltration were higher in
the MWCNT or MCA +MWCNT groups relative to the
air or MCA groups (Table 1). It was seen as occasional,
random, small clusters of macrophages in airways or
alveoli, or as slightly increased numbers in interstitial
connective tissues often near terminal bronchioles or
alveolar ducts.
Lung adenoma and adenocarcinoma
The incidences, or number of mice with tumors, of
bronchiolo-alveolar adenoma, bronchiolo-alveolar adeno-
carcinoma, and their combined incidence was greatest in
the MCA+MWCNT group relative to the other groups
for each individual lung lobe and for the entire lung con-
sidered as a single tissue (Table 2).
Bronchiolo-alveolar adenomas were focal, densely
cellular, slightly compressive masses that distorted alveo-
lar architecture and replaced alveolar spaces (Figure 4).
The masses were composed of proliferative epithelial
cells that formed irregular papillary structures, ribbons,
or solid clusters separated by delicate, fibrovascular
stroma. The cells were polygonal, moderately uniform in
size, and had small to moderate amounts of eosinophilic,
occasionally vacuolated cytoplasm. Nuclei were small,
round to oval, moderately uniform with inconspicuous
nucleoli, and mitoses were few to absent. At terminal
Figure 3 Hyperplasia. A Focal adenomatous hyperplasia in a mouse exposed to i.p corn oil and inhaled MWCNT. A. At low magnification, a
focus of bronchoalveolar hyperplasia forms a discrete, hypercellular focus that retains normal alveolar architecture (bar = 200 microns). B. At
higher magnification, the hypercellularity is attributable to a population of hypertrophied epithelial cells characterized by moderate anisokaryosis
and mild karyomegaly. To distinguish these foci from foci of reactive hyperplasia and because of morphologic similarities to atypical adenomatous
hyperplasia in the human lung, we have used the term focal adenomatous hyperplasia for these foci. MWCNT were sometimes seen within or near
these foci (bar = 50 microns).
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iolo-alveolar adenomas in the MCA followed by air and
MCA +MWCNT groups were 33% and 76%, respect-
ively, exceeding the air (11%) and MWCNT (18%)
groups. The NTP has reported a range of 2-30% lung
adenomas in vehicle control B6C3F1 male mice thus
indicating that the mice in the current study have a
spontaneously-occurring lung adenoma incidence within
the range expected in this mouse strain (Table 3) [24].
Furthermore, the morphology of bronchiolo-alveolar
adenomas in the groups that received MCA and/or
MWCNT did not differ appreciably from the spontan-
eously occurring neoplasms in the air group.
In contrast to bronchiolo-alveolar adenomas, bronch-
iolo-alveolar adenocarcinomas had increased cellular
atypia, higher nuclear to cytoplasmic ratios, and larger
nucleoli (Figure 5A). Several cytologic patterns were often
present within the same mass, and included ribbons,
papillary structures, or solid clusters (Figure 5B and 5C).
The incidences of bronchiolo-alveolar adenocarcinomas
in the MCA and MCA+MWCNT groups were 22% and
62%, respectively, exceeding the air (13%) and MWCNT
(14%) groups (Table 3). The incidence of bronchiolo-
alveolar adenocarcinoma in the MCA +MWCNT group










MCA +MWCNT 42 90.5*
*Indicates statistical significance at p < .0001 ± indicates standard deviation.range of 4-24% for male B6C3F1 mice [24]. The combined
incidences of bronchiolo-alveolar adenoma and bronch-
iolo-alveolar adenocarcinoma in the MCA or MCA +
MWCNT groups were 51.9% and 90.5%, exceeding the air
(23.2%) and MWCNT only (26.5%) groups, and exceeding
or greatly exceeding the NTP historical vehicle control
range for male B6C3F1 mice (14-40%), respectively [24].
The number of bronchiolo-alveolar adenomas and
bronchiolo-alveolar adenocarcinomas was increased in
the MCA and MCA +MWCNT groups relative to the
Air or MWCNT groups (Table 3). The numbers of these
neoplasms were greatest in the MCA +MWCNT group
relative to the other groups. The MCA +MWCNT
treated mice had a mean of 2.9 tumors/mouse compared
to 0.81 in MCA, 0.25 air alone and 0.38 MWCNT-
treated mice (Table 2). The volume of the lung occupied
by tumor was greater in the MCA +MWCNT compared
to the other groups (Figure 6). Three mice exposed to
both MCA and MWCNT that were euthanized early
had tumors with evidence of local invasion of the lung
tissue (5.5%). Figure 5D demonstrates lung adenocarcin-
oma tissue invading a vein.
Animals that were euthanized early were analyzed
separately from the mice that were euthanized 17 months







17 0.25 ±0.166 7
41* 0.81 ±0.167 14*
20 0.38 ±0.185 7
133* 2.9 ±0.386* 56*
Figure 4 A, B and C Lung adenoma, 20× and 40×. A. The figure is a representative pulmonary bronchio-alveolar adenoma from a male
B6C3F1 mouse treated with MCA +MWCNT. The mass is composed of relatively uniform cells that compressed the surrounding lung tissue.
The photo with taken with a 4x objective. The magnification bar is 200 microns. B. Figure 4B is a photomicrograph of a pulmonary bronchiolo-alveolar
adenoma from a MCA +MWCNT treated mouse. The focal, moderately cellular mass involved a bronchiole. The mass was composed of relatively
uniform cells that distorted and replaced alveolar architecture. The image was photographed using a 20x objective. The magnification bar is
50 microns. C. The light micrograph is a higher magnification of the H&E stained section demonstrating MWCNT (black fibers) in the tissue surrounding
the bronchiolo-alveolar adenoma (arrows 1, 2 and 3). The light microscope image was taken using 100x oil immersion objective. The magnification
bar is 20 microns.
Table 3 Incidence of lung tumors in early euthanized mice and mice 17 months after exposure
Euthanasia Early sacrifice Terminal sacrifice
Air MCA MWCNT MCA +MWCNT Air MCA MWCNT MCA+MWCNT
Number of animals 4 6 6 13 56 54 49 42
Number of Bronchiolo-alveolar
adenomas
0 1 0 4 6 18* 9 32*
% of mice with one or more
Bronchiolo-alveolar adenoma
0% 17%* 0% 31%* 11% 33%* 18% 76%*
Number of Bronchiolo-alveolar
adenocarcinomas
0 1 0 7 7 12 7 26
% of mice with Bronchiolo-alveolar
Adenocarcinomas
0% 17%* 0% 54%* 13% 22%* 14% 62%*




0 2 0 8 13 28* 13 38*
Percent of mice with lung tumors 0% 33% 0% 62%* 23.2% 51.9%* 26.5% 90.5%*
*Indicates statistical significance at p < .0001.
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Figure 5 Pulmonary bronchiolo-alveolar adenocarcinomas in MCA +MWCNT treated mice. A. The photomicrograph shows a right cardiac
lung lobe of a MCA +MWCNT-treated mouse that contains a bronchiolo-alveolar adenocarcinoma (white arrow). A bronchiolo-alveolar adenoma
(black arrow) is in the adjacent lung lobe. (2x). The magnification bar is 500 microns. B. The figure is a photomicrograph of a bronchiolo-alveolar
adenocarcinoma in the right cardiac lobe of a mouse lung treated with MCA +MWCNT (20x). This infiltrative adenocarcinoma filled ~85% of the
lobe on histologic cross section. The scale bar is 200 microns. C. The photomicrograph is a higher magnification of the bronchiolo-alveolar
adenocarcinoma of the right cardiac lobe in figure B showing heterogeneous growth and pleomorphic cytologic features (40x). The scale
bar is 50 microns. D. The photomicrograph shows a metastasis of the bronchiolo-alveolar adenocarcinoma in the right cardiac lobe of a
mouse lung 17 months following treatment with MCA + MWCNT (40×). The arrow demonstrates a metastasis in a pulmonary vein.
The scale bar is 50 microns.
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exposed control mice were terminated due to a 20% loss
of their body weight. One of the four air controls had a
dental tumor at euthanasia. No other lesions or lung
tumors were observed in the air mice either grossly or
by pathological analysis. Six of the animals exposed only
to MWCNT were euthanized early due to morbidity.
These mice were euthanized due to significant weight
loss and one animal was found to have an enlarged
heart. Two of these mice had liver tumors. No lung
tumors were observed in the early euthanized mice that
were only exposed to MWCNT. Six animals treated with
MCA followed by air were euthanized early due to a
20% or greater weight loss. One MCA mouse had a lung
adenoma and one mouse had a lung adenocarcinoma.
Thirteen of the animals treated with MCA followed by
MWCNT were euthanized due to significant weight loss.
Seven animals treated with MCA followed by MWCNT
had lung tumors (Table 3). The life table demonstrates
the time period of early deaths (Figure 7). The mean age
of death of the animals that were euthanized early
was as follows: 11.18 ± 2.08 months in the air group,12.28 ± 0.72 months in the MCA group, 10.63 ±
1.27 months in the MWCNT treatment group and
11.22 ± 1.58 months in the MCA +MWCNT-treated
group (Figure 7). There was not a significant differ-
ence in the age of death between groups.
Serosal tumors
Malignant serosal tumors morphologically consistent
with malignant sarcomatous mesotheliomas were seen
in five mice (9%) in the MCA +MWCNT group and one
mouse (2%) in the MCA group (Table 4, Figure 8).
Consistent with the serosal dissemination of malignant
mesotheliomas, multiple tissues were affected in four of
the six affected mice. Spontaneous mesotheliomas in
B6C3F1 mice are rare [24]. In recent years, a series of
immunologic markers have been developed to augment
the morphologic diagnosis of mesothelioma in man
[34,35]. For that reason, we further characterized the
serosal tumors by immunofluorescence (IF) for vimen-
tin, cytokeratin and podoplanin in at least one tumor
from each affected mouse. All presumptive sarcomatous
mesotheliomas stained positively for podoplanin and
Table 4 Malignant serosal tumors in MCA +MWCNT
Exposed Mice
MCA +MWCNT MCA
Mesothelioma by animal # 76 245 261 301 309 192




Bronchial lymph node X
Skeletal muscle diaphragm X X X X
Pancreas X X
Mesentery X X X X X
Lungs X
Figure 6 Volume of lung tumors 17 months after exposure to
MWCNT. The figure demonstrates the volume of the lung occupied
by tumor per individual mouse. The volume of the lung occupied
by tumor was greater in the MCA +MWCNT (361 mm3+/−18.72)
compared to the mice treated with MCA (202.61 mm3+/−36.75).
The MWCNT group had an average tumor volume of 107.88 mm3+/−
28.70 compared to the negative control, Air group, with a volume of
22.29 mm3 +/− 3.93. *Indicates a significant difference compared to
the respective air control group at p < .0001.
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all tumors evaluated from 5 mice and in one mouse
varied from weakly to strongly positive in three different
serosal tumors. Two wide-specrum cytokeratin anti-
bodies were used because of the variable cytokeratin
staining of sarcomatous mesotheliomas in man (Figure 9)
[36,37]. Cytokeratin staining with a mouse anti-wide
spectrum cytokeratin antibody was negative in four miceFigure 7 Life table of mice treated with one dose of corn oil
(Air), MC (MCA), MWCNT only MWCNT or MCA followed by
MWCNT (MC +MWCNT). The life table in Figure 7 shows the
percent of mice alive in each treatment group at 30 weeks after
exposure to the time of sacrifice 70 weeks after exposure. The
MCA +MWCNT treated animals had a greater number of early
deaths than the MWCNT, the MCA or the Air treated mice.
Figure 8 Malignant serosal tumors in the lung (A) and the
diaphragm (B) in mice exposed to MC followed by MWCNT.
A. The photomicrograph shows a pulmonary vein in the right
cardiac lung lobe that contained variably-sized polygonal to
spindloid cells similar to those on the diaphragm (Figure 8B). The
arrow indicates a metastasis of the malignant serosal tumor (20×).
The magnification bar is 50 microns. B. The skeletal muscle of the
diaphragm in the photomicrograph is infiltrated by a nodular
mass composed of variably-sized polygonal to spindloid cells
(malignant serosal tumors). (20×). The magnification bar is 50 microns.
Figure 9 Immunofluorescence staining for podoplanin (red) and cytokeratins (green) in malignant serosal tumors morphologically
consistent with sarcomatous mesothelioma. In A, the lining mesothelium (solid arrows) stained positively for podoplanin in this double label
immunofluorescent image of diaphragm. The cells beneath the mesothelial lining are also red due to expression of podoplanin and these are
cells of a malignant serosal tumor. In B, only the single label green fluorescence is shown to demonstrate weak expression of cytokeratins in the
lining mesothelium (solid arrow), while staining of the subjacent tumor for cytokeratins is equivocal. In C, a double label immunofluorescent
image demonstrates a malignant serosal tumor between the liver and gall bladder that is lined by reactive mesothelium (solid arrow) which
stains red for podoplanin as well as green for cytokeratins. The cells of the subjacent malignant serosal tumor stain weakly red for podoplanin.
In D, the photomicrograph shows this same tumor but only the green fluorescence for cytokeratins. The reactive mesothelium lining the
malignant serosal tumor (solid arrow) stains green for cytokeratins while the serosal tumor has no evidence of cytokeratin expression. The normal
mesothelium lining the liver is weakly positive for cytokeratins (dashed arrow). The epithelium lining the gall bladder (open arrow) strongly
expresses cytokeratins. Magnification bar is 50 μm.
Sargent et al. Particle and Fibre Toxicology 2014, 11:3 Page 9 of 18
http://www.particleandfibretoxicology.com/content/11/1/3and equivocal in two. Cytokeratin staining with a rabbit
anti-pancytokeratin antibody was negative in tumors
from four mice and equivocal to faintly positive in
tumors from two mice.
Discussion
The primary objective of this investigation was to evalu-
ate if exposure to aerosolized MWCNT promotes the
growth of DNA damaged cells and/or is a complete
carcinogen. To accomplish this, mice were exposed to
aerosolized MWCNT (5 mg/m3, 5 hours/day) for 15 days.
Initial MWCNT lung burden in these mice was 31.2 ±
0.9 μg MWCNT/mouse [38]. In order to evaluate the
relationship of these MWCNT lung burdens to human
MWCNT exposures, we compared the MWCNT lung
burdens in these mice with potential human occupational
exposures. OSHA has not yet established exposure limits
for carbon nanotubes; however, MWCNT are regulated asrespirable particulates not otherwise regulated (PNOR).
The PNOR have an OSHA Permissible Exposure Limit
(PEL) of 5 mg/m3 [39]. NIOSH recently published a
Current Intelligence Bulletin with a Recommended
Exposure Limit (REL) of 1 μg/m3 for carbon nano-
tubes which is 5000-fold lower than the OSHA PNOR
PEL [40].
Assuming a mouse alveolar epithelium surface area of
0.05 m2 [41], the 31.2 μg MWCNT lung burden would
result in 624 μg MWCNT/m2 alveolar epithelium. Using
the alveolar epithelial surface area of 102 m2 for human,
the equivalent human lung burden would be 63.6 mg [41].
If the MWCNT mass median aerodynamic diameter
(MMAD) =1.5 μm were used, minute ventilation of
20 L/minute for a person performing light work [42]
and an alveolar deposition fraction of 30% [43] (for 240
work days per year), the equivalent lung burden in
workers exposed at the previous draft REL for CNT of
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[44]. This indicates that the mouse MWCNT lung
burdens in this study approximate feasible human occu-
pational exposures.
Inhalation of multi-walled carbon nanotubes (MWCNT)
for 15 days following a single intraperitoneal injection
of the known initiator MCA led to increased inci-
dence and numbers of bronchiolo-alveolar adenomas
and bronchiolo-alveolar adenocarcinomas in B6C3F1
male mice. The combined incidence of bronchiolo-
alveolar adenomas and bronchiolo-alveolar carcinomas
of 90.5% for the MCA +MWCNT group greatly exceeded
that in groups of mice exposed to air or MCA and the
NTP historical vehicle control range for B6C3F1 male
mice [24]. Additionally, the numbers of bronchiolo-
alveolar adenomas or bronchiolo-alveolar adenocarcin-
omas were greatest in the MCA +MWCNT group
compared to other groups. The data demonstrate that
MWCNT may act as a carcinogen that promotes the
growth of initiated lung cells, resulting in the devel-
opment of lung adenocarcinoma.
The strong tumor promotion that was observed in the
current study may have resulted from a combination of
effects that have been observed following exposure to
carbon nanotubes. MWCNT material was observed in
the diaphragm and in the lungs, both within macro-
phages and the interstitium. MWCNT are internalized
by macrophages following pulmonary exposure. In
addition, MWCNT material has been observed in the
interstitium. MWCNT exposure has been shown to
induce fibrosis as early as seven days post-exposure
[8,10,45]. In previous experiments, the post-exposure
pulmonary distribution, pulmonary fibrotic response and
transport of MWCNT to systemic organs were exam-
ined at various times post-exposure, from 1 to 336 days
[46,47]. Fibrillar collagen in the lungs was specifically
stained and the quantity of fibrillar collagen in the
alveolar region was measured by morphometry. These
measurements of fibrillar collagen in the alveolar region
of the lungs demonstrated a fibrotic response to inhaled
MWCNT which was significantly above vehicle controls
and progressively increased throughout the 336 days
post-exposure study period [46]. These studies have
demonstrated that inhaled MWCNTs are deposited
throughout the alveolar region of the lungs and are
retained in the alveolar tissue. Additionally MWCNT
were demonstrated in the visceral pleura, pleural space
and parietal space [9]. MWCNT that penetrate the
visceral pleural induce pleural inflammation and cell
proliferation in a manner similar to asbestos [8,48,49].
MWCNT have further been shown to penetrate the
cytoplasmic membrane and nuclear envelope [50,51].
Asbestos and MWCNT also induce inflammation,
fibrosis, cell proliferation and cellular atypia in the lung[8,48,49]. Cell proliferation and inflammation are im-
portant events in the promotion of cancer [16,17,52-55].
Indeed in the current study, inhaled MWCNT induced
dramatic hyperplasia and a moderate increase in aden-
omas however, the increase in adenomas was not statis-
tically significant. In addition, MWCNT exposure did
not result in an increased number of adenocarcinomas.
The significant hyperplastic response that was observed
after exposure to MWCNT material without prior initi-
ation indicates that the material was a tumor promoter.
The dramatic increase in adenomas and adenocarcinomas
after MCA initiation followed by MWCNT-exposure
demonstrate that inhaled MWCNT material is a strong
tumor promoter. Strong tumor promoters increase the
growth of chemically initiated as well as spontaneously
initiated cells [56,57]. Although the data of the current
investigation do not indicate that inhaled MWCNT
material act as tumor initiators, the data demonstrate the
strongest promotion response observed in the lung using
occupationally relevant material [15,52,58-60]. The data
further indicate that MWCNT may initiate lung responses
similar to the carcinogenic fiber asbestos [4,61-63].
The dimensions of the nanotubes as well as their
surface properties are important in the inflammatory
response. Pulmonary exposure to SWCNT and MWCNT
causes inflammation and fibrosis; however, the inflamma-
tory response following MWCNT exposure is more pro-
nounced than the response observed following SWCNT
exposure [8,64,65]. The degree of inflammation resulting
from asbestos and MWCNT is determined by the diam-
eter and the length [4,66,67]. Carbon nanotubes of
approximately 50 nm in diameter cause more inflamma-
tion than nanotubes of less than 20 nm or greater than
150 nm [67]. In addition, the rigid MWCNT of 40–50 nm
diameter and at least 4 microns long were the most
inflammatory [67,68]. Although these studies indicate that
the diameter and length of carbon nanotubes may alter
MWCNT-induced carcinogenicity further investigations
are required to fully characterize the role of the dimen-
sions as well as the physical properties in the carcinogenic
response.
Classical multistep carcinogenesis models involve
initiation, promotion and progression. Exposure to a
genotoxic agent initiates a population of genetically
altered cells which expand in number through the action
of promoters and undergo additional genetic changes
during the progression process [16,17,69]. Several stud-
ies suggest both genotoxicity and promotion from the
classical carcinogenic high aspect ratio particle, asbestos.
Oxidant generation from inflammation has been shown
to damage the DNA and can initiate cancer [54]. Asbes-
tos and carbon nanotubes have been shown to induce
disruption of the cell division apparatus and errors in
chromosome number (aneuploidy) in vitro [12,14,70].
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diameter and at least 5 microns in length are the most
genotoxic [71,72]. The mutagenicity of asbestos fibers is
correlated with the potency as a carcinogen [73]. Evi-
dence from epidemiological studies has demonstrated
that asbestos can act as a tumor promoter at low doses
as well as a tumor initiator at longer and/or higher
exposure levels [74]. In several human epidemiology
studies, smoking exposure and asbestos interact in a
more than additive fashion in causing lung cancer
[75-79]. There are multiple mutagens in cigarette smoke
that have the potential to initiate cancer [80]. Humans
are also potentially exposed to many other mutagens
that could initiate cancer such as radon, polychlorinated
biphenyls, hexavalent chromium, naphthalene and
benzo-a-pyrene in diesel exhaust [81-85]. Thus, it is
plausible to suggest MWCNT could potentially act as
promoters in individuals who smoke or are exposed to
other initiators.
Previous studies to examine rodent exposure to asbes-
tos by inhalation or pharyngeal aspiration have shown
that asbestos is carcinogenic in the rat lung by this route
but only weakly positive in the mouse [86-88]. The data
demonstrating that asbestos induces mitotic spindle
disruption and aneuploidy would suggest that asbestos
would be a strong tumor promoter; however, asbestos
has not been administered in an initiation/promotion
protocol in a mouse model. Although lung cancer has
not been observed in either rats or mice following the
intraperitoneal injection of asbestos or carbon nano-
tubes, mesothelioma has been reported. Abdominal or
scrotal injection of mice with asbestos or long thin
MWCNT of at least 3.9 micron in length and 50 nm in
diameter caused mesotheliomas in p53 +/− transgenic
mice and Fischer rats [20,21]. Recent investigations
demonstrated that intraperitoneal injection of as little as
3 μg of MWCNT in genetically modified mice (p53+/−)
induced mesothelioma [23]. By contrast, an IP exposure
of Wistar rats to short MWCNT of < 1 micron in length
resulted in mesothelioma in 5/150 MWCNT-exposed
animals but those findings were not statistically
significant due to a high peritoneal mesothelioma rate in
the control group [89]. The high background rate of
peritoneal mesotheliomas (1/26) is unusual for the
Wistar rat [89-91]. A subsequent study demonstrated
that high exposures (1 and 10 mg/rat) of thin, rigid
MWCNT by intraperitoneal injection caused mesotheli-
omas (54). When the diameter of the nanotubes was
considered, MWCNT of 50 nm in diameter were more
carcinogenic than nanotubes of less than 20 nm or
greater than 150 nm [67]. These findings suggest that
the diameter and length are critical in the carcinogenic
response to MWCNT, a finding that is similar to clas-
sical studies of asbestos fiber carcinogenicity [92].A limitation of the current study is that suitable non-
carcinogenic particle controls do not exist in this model.
We considered using the short multi-walled carbon
nanotubes investigated by Muller et al., as a potential
negative control [89]. However, since the interpretation
of the Muller et al. study is affected by the unusual high
background rate of peritoneal mesothelioma in the
control group, this particle cannot be considered a
confirmed negative control nor could we identify any
carbon nanotube as a confirmed negative particle
control for a carcinogenicity study. The identification of
a suitable negative control nanotube will require further
carcinogenicity studies that have yet to be published.
Malignant mesothelioma in humans has three major
histologic patterns: epithelial, sarcomatous (sarcomatoid),
and biphasic [93,94]. Using standard histopathology, the
major differential diagnoses for malignant mesothelioma
include broncho-alveolar adenocarcinoma of the lung,
metastatic carcinoma and metastatic sarcoma [94]. The
diagnosis of malignant mesothelioma in humans can be
supported by staining for proteins commonly expressed in
mesotheliomas, including calretinin, cytokeratins, meso-
thelin, WT-1 and podoplanin (D2-40) [34]. Podoplanin is
among the markers most consistently expressed in human
malignant sarcomatous mesotheliomas [34,95]. The ma-
lignant serosal tumors seen in the mice in our study con-
sistently expressed podoplanin. However, the staining for
cytokeratins was negative to equivocal, a finding that is
also sometimes seen in sarcomatous mesothelioma in
humans [35,36]. One review noted that only 13% of
human sarcomatous mesotheliomas were positive for
cytokeratin 5/6 and none were positive for seven other
epithelial markers [37]. However, in one study using a
cocktail of mouse anti-human monoclonal antibodies,
93% of the cases of human sarcomatous mesotheliomas
demonstrated cytokeratin expression [96]. However, there
are protein sequence differences between human and
mouse cytokeratins. In addition, even with blocking steps,
indirect immunohistochemistry using mouse antibodies
on mouse tissues results in some degree of binding of the
secondary anti-mouse IgG antibody with endogenous IgG
located in the mouse tissue. It is for this reason that we
used both a mouse monoclonal antibody and a rabbit
anti-pancytokeratin antibody to stain for cytokeratins in
this study. However, the negative to equivocal staining of
the serosal tumors for cytokeratins in this study should be
interpreted with an understanding that mesotheliomas are
very rare in the mouse and that techniques for identifying
mesothelioma markers in mice are not as advanced as
they are for identifying those markers in human tissue.
The negative staining does not mean that there are no
cytokeratins in the serosal tumors of our study, only that
no cytokeratins could be identified with the antibodies
used in this study.
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keratin staining can be seen in several different sarcomas
as well as in malignant mesothelioma [34,97]. The
malignant serosal tumors seen in this study were
morphologically consistent with malignant sarcomatous
mesotheliomas with five of the six tumors involving
multiple peritoneal serosal surfaces. The remaining
malignant serosal tumor was limited to the male uro-
genital tract, a common site for mesothelioma in rats
but not in control mice [98]. In humans, a diagnosis of
cytokeratin negative sarcomatous mesothelioma is usu-
ally made by excluding other potential diagnoses [36].
Given the rarity of mesotheliomas in the mouse, we
could not exclude other diagnoses with absolute
certainty [24]. Thus, the characteristics of these tumors
are consistent with, but not diagnostic of, mesothelioma.
The principal differential diagnosis is pleural sarcoma.
These tumors are considered similar to the serosal
tumors diagnosed as pleural sarcomas or malignant
mesenchymal neoplasms in the classical asbestos studies
in rats conducted by Stanton and co-workers who noted
their comparability to human mesotheliomas [92].
Conclusions
This study is the first to demonstrate that inhalation
exposure to some MWCNTs promotes the growth of
initiated lung cells in a wildtype mouse. Ninety percent of
the mice exposed to MCA followed by MWCNT had lung
adenocarcinoma and adenomas (mean of 2.9/mouse)
compared to 23% of the filtered air controls (mean of
0.25/mouse), 26.5% of the MWCNT-exposed (mean of
0.38/mouse), and 51.9% of the MCA followed by air-
exposure (mean of 0.81/mouse). The data therefore
demonstrate that inhaled MWCNT are strong promoters
of pulmonary adenomas and adenocarcinomas in B6C3F1
mice. Furthermore, the strong tumor promotion response
observed following exposure to MWCNT was observed in
a hybrid mouse that is intermediate in sensitivity to lung
cancer [25,26]. Because this B6C3F1 hybrid is used by the
NTP to determine potential carcinogenesis, the study can
be compared to a wealth of historical data generated by
the NTP [24].
Furthermore, the current investigation suggests that
inhaled MWCNT can promote the growth of malignant
serosal tumors consistent with sarcomatous mesotheli-
oma. MWCNT inhalation increased the incidence from
2% in the MCA exposed mice to 9% in the MCA +
MWCNT, a 4.5 fold increase. However, malignant
serosal tumors are uncommon tumors in mice and their
potential promotion by MWCNT is of concern. NIOSH
is undertaking an inhalation exposure designed to
further evaluate the potential for MWCNT to cause
mesothelioma. The mouse MWCNT lung burdens in the
investigation are relevant to feasible human occupationalexposures. While extrapolation to human health is prema-
ture, humans working with MWCNT may be exposed to
numerous tumor initiators in the course of their daily
lives. Results from this study suggest that caution should
be taken during production and processing to limit
human inhalation exposures to MWCNT.
Methods
MWCNT
MWCNT used in this study were obtained from Hodogaya
Chemical Company (Mitsui-7 MWNT-7, lot #061220-31)
and were manufactured using a floating reactant catalytic
chemical vapor deposition method followed by high
temperature thermal treatment in argon at 2500°C using a
continuous furnace [99]. The bulk material was character-
ized by high-resolution transmission electron microscopsy
under a Philips CM 20 transmission electron microscope
(TEM) with an EDS (EDAX/4p1) as described previously
[100]. MWCNT trace metal contamination of 1.32% with
iron being the major metal contaminant was 1.06% [101].
MWCNT inhalation exposure and aerosol characterization
The MWCNT aerosol was generated using an acous-
tical-based computer controlled whole body inhalation
system designed and constructed by McKinney et al,
[100]. In brief, the inhalation exposure system combines
air flow controllers, aerosol particle monitors, data ac-
quisition devices, and custom software with automated
feedback control to achieve constant and repeatable
exposure chamber temperature, relative humidity, pres-
sure, aerosol concentration, and particle size distributions.
The generator produces airborne particles continuously
for long periods of time with minimal fluctuations during
an exposure period. The uniformity of test atmosphere in
the chamber was evaluated to have a total variation
of <5%. In this study, the MWCNT aerosol mass
concentration was continuously monitored with a
Data RAM (DR-40000 Thermo Electron Co, Franklin,
MA), and gravimetric determinations (37 mm cassettes
with 0.45 μm pore-size Teflon filters) were used to cali-
brate and verify the Data RAM readings. Chen et al. have
provided a detailed characterization of MWCNT samples
taken from the animal exposure chamber [102]. In
addition, cascade impactors (MOUDI, Models 110 and
115, MSP Co., Shoreview, MN) were used to determine
the mass-based particle size distributions by fractionating
the particles into 15 size fractions ranging from 10 nm to
18 μm. The mass median aerodynamic diameter was de-
termined to be 1.59 μm and geometric standard deviation
of 1.69. The count mode aerodynamic diameter was
0.42 μm [101,102]. The target concentration of the mouse
exposure was 5 mg/m3 for a duration of 5 hours/day
for 15 days, with an accumulative exposure dose of
375 mg/m3 × hr. The values of detailed exposure
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Based on data from Data RAM and filter samples, the
mean concentrations among the 5 exposures were consist-
ent at 4.6-4.7 mg/m3 with a daily variation between 4–8%.
Depending on the concentration measured daily, the
exposure time was adjusted accordingly to result in the
target dose of 375 mg/m3 × hr. The mean exposure time
per day was 320–330 minutes with a daily variation
between 1–3%. The accumulated dose was measured
between 372 and 379 mg/m3 × hours and therefore was
very close to the target dose of 375 mg/m3 × hr. In brief,
the study was well conducted to fulfill the exposure
design.
Initiation promotion protocol
Six week old male B6C3F1 mice (Jackson Laboratories, Bar
Harbor, ME) were housed singly in a polycarbonate venti-
lated cage with HEPA-filtered air. Male mice were selected
for the investigation because the preliminary data showing
dose response, proliferation of type II cells, cellular atypia
and migration of particles following carbon nanotube ex-
posure were gathered using male mice [7-9,103]. The mice
were fed ad libitum with Harlan 7913 irradiated NIH-31
modified 6% rodent chow. The initiation, promotion proto-
col developed previously by Alvin Malkinson was followed
[15]. After a one week acclimation period, mice (60/group)
were randomly assigned to a treatment group. The mice
were treated following a two stage (initiation-promotion)
protocol. An initiation-promotion protocol involved the
administration of a low dose of a DNA damaging agent
(methylcholanthrene, MCA) followed by administration of
a suspected carcinogen that would promote the growth of
DNA damaged cells (MWCNT). All mice received a single
dose of either MCA (10 μg/g BW, i.p.) or vehicle (corn oil).
One week after receiving MCA, mice were exposed to
MWCNT by whole body inhalation (5 mg/m3, 5 hours/
day) or filtered air (controls) for 15 days. Mice were eutha-
nized 17 months after exposure to allow time for tumor
development. Mice were divided into five blocks with stag-
gered test substance administration start and end dates.
Because animals developing lung tumors have non-
specific symptoms but may develop general signs of pain
and distress, animals were monitored weekly for overt
signs of morbidity and changes in body weight. Animals
with skin lesions, ruffled fur, lethargy, shaking, penis or
anal prolapse, erratic movements or paralysis were
closely monitored for further signs of distress. Animals
that had a loss of 20% or greater of body weight, were
hunched or developed hind leg paralysis were eutha-
nized for morbidity prior to the terminal sacrifice.
Foreign material in lung tissues
MWCNT burden determinations were made using a
procedure previously developed with minor modification[38]. After euthanasia, lungs were removed and frozen
at −80°C and preserved for further processing. The
lung tissue was digested in 25% KOH/methanol (w/v)
at 60°C overnight, followed by centrifugation at 16,000 × g
for 10 minutes. The supernatant was removed; the
remaining pellet was mixed with 50% HNO3/methanol
(v/v), and incubated at 60°C overnight, followed by
centrifugation (16,000 × g, 10 minutes). After centrifuga-
tion, the supernatant was removed, and the pellet was
resuspended in 10% NP-40 (v/v) in dH2O, followed by
30 second sonication using cup horn sonicator. MWCNT
standards were processed in parallel with the lung sam-
ples. The optical densities of the solutions were measured
at 700 nm using a UV/visible spectrophotometer. Lung
MWCNTcontent was determined from a standard curve.
Necropsy, histopathology and tumor counts
Groups of mice were divided into five blocks with stag-
gered test substance administration start and end dates.
The lungs and any masses from mice euthanized early
were noted and the tissues collected for pathological
analysis. The mice euthanized early, due to signs of mor-
bidity [8], were analyzed separately from animals that
were sacrificed 17 months after exposure. Mice were
euthanized with an overdose of ≥100 mg/kg bw pento-
barbital and exsanguinated. The lungs were fixed by
intratracheal perfusion with 1 ml of 10% neutral buffered
formalin. The mice were then necropsied following
standard techniques [45]. Masses and lesions seen
grossly were recorded on individual animal necropsy
records (IANRs). The length, width and height of masses
were measured in the MCA, air, MWCNT and MCA +
MWCNT-treated mice, using a digital caliper. The cal-
culations of the tumor volumes for spherical masses
were done using (4/3 π)(r3) and for non-spherical masses
(Length × Width × Height). All gross lesions and masses
were then collected and fixed in 10% neutral buffer
formalin (NBF). Lungs and any lesions were trimmed
the same day and processed overnight. Tissues were em-
bedded in paraffin, and sectioned at approximately
5 μm. Hematoxylin and eosin (H & E) stained slides
were prepared each of the five separate lung lobes and
from masses seen at necropsy. The tumor counts were
based on histopathological analysis.
Slides were examined by a board certified veterinary
pathologist using light microscopy or polarized light,
which was occasionally used to confirm the presence or
absence of foreign material (presumptive test material).
The severity of non-neoplastic lesions was graded on a
4-point scale of minimal (1), mild (2), moderate (3), or
marked (4) using an adaptation of previously described
methods [104]. Presumptive MWCNT (foreign material)
was recorded when present without severity grade [104].
Focal adenomatous alveolar hyperplasia was characterized
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that outlined contiguous alveolar septa in discrete, gener-
ally random locations (Figure 3). Severity was considered
minimal, mild, moderate, or marked if roughly <5, 5–10,
11–20, or >20 contiguous alveoli were affected, respect-
ively. Severity was increased or decreased a grade based
on cell density and crowding. Histologic diagnoses were
entered into the Provantis® data collection and manage-
ment system. All lung slides from 10% of the mice in the
terminal sacrifice were randomly selected for evaluation
by a second board-certified veterinary pathologist who
independently evaluated the slides while blinded to the
interpretation of the study pathologist. There was 100%
concordance on the diagnosis of neoplasia and 87%
concordance on the diagnosis of adenocarcinoma versus
adenoma. The differences were in the diagnosis of adeno-
carcinoma versus adenoma were considered by both the
peer review and study pathologist to involve borderline
lesions where such differences would be expected.
Tumor multiplicity (Table 2) was analyzed two ways.
First, the number of tumors was divided by the number
of animals that had tumors in each treatment group and
was labeled “mean # of lung tumor per mice with
tumors”. Secondly, the multiplicity was determined by
dividing the number of tumors by the number of animals
in the treatment group and was labeled “lung multiplicity
adjusted by the total number of mice” (Table 2).
Immunofluorescent detection of markers for
mesothelioma
Immunofluoresecent staining for mesothelial proteins
were performed on sarcomatous tumors of the periton-
eal and epididymal surface in mice exposed to both
MWCNT and MCA. Proteins identified by immuno-
fluorescence were cytokeratins (wide spectrum), vimen-
tin and podoplanin based upon their previously
described expression in mouse or human mesothelioma
[34,105-107]. To localize sites of vimentin and podopla-
nin expression to sites of cytokeratin expression, the
immunofluorescence staining used double labeling for: 1)
cytokeratin and vimentin, and 2) cytokeratin and podopla-
nin. Immunofluorescence was selected because it is more
sensitive for identifying fluorescence in long, thin cyto-
plasm such as in alveolar type I cells or normal mesothe-
lial cells [108].
For immunofluorescent staining, slides were deparaffi-
nized, antigenicity was retrieved using EDTA, and non-
specific reactivity was blocked with normal donkey
serum (017-000-121, Jackson ImmunoResearch Labora-
tories, West Grove, PA), as previously described [108].
Two primaries from different species were used for each
double label. Primary antibodies were hamster anti-
podoplanin (NB600-1015, Novus Biologicals, Littleton,
CO), mouse anti-pancytokeratin (C2652, Sigma-Aldrich,St Louis, MO), rabbit anti-vimentin (GTX62264, Gene-
Tex, Irvine, CA), and rabbit anti-wide spectrum cytokera-
tin (rabbit ab9377). Secondary anti-bodies were DyLight
488, donkey anti-mouse (715-486-150, lot# 97733, Jackson
ImmunoResearch Laboratories, West Grove, PA), DyLight
594 goat anti-hamster (107-515-142, lot 90054, Jackson
ImmunoResearch Laboratories, West Grove, PA), Dylight
488 F(ab’)2 donkey anti-rabbit and DyLight 594 donkey
anti-rabbit (711-516-152, lot 97356, Jackson ImmunoRe-
search Laboratories, West Grove, PA). Nuclei were stained
using DAPI Fluoro Pure and slides were cover slipped
with Prolong anti-fade reagent. Negative control slides
were treated identically except that the primary antibody
was replaced with non-immune serum from the same spe-
cies as the primary antibody. Positive control slides were
the normal mesothelial lining of the liver and lung.
Enhanced-darkfield light microscopy imaging of
nanoparticles
Carbon nanotubes in sections from exposed lungs were
assessed using an enhanced-darkfield optical system as
previously described [6]. Nanomaterials, such as carbon
nanotubes, have dimensions less than the wavelength of
light, have closely packed atoms, and typically have a
refractive index significantly different from that of
biologic tissues and/or mounting medium. These charac-
teristics produce significantly greater scattering of light
by nanoparticles than by the surrounding tissues and are
visible with high contrast when examined with an
enhanced-darkfield optical system designed to image
scattered light in the section.
The optical system consisted of high signal-to-noise,
darkfield-based illumination optics adapted to an Olympus
BX-41 microscope (CytoViva, Auburn, AL 36830). Sec-
tions for dark-field examination were cut from paraffin
blocks and collected on ultrasonically cleaned, laser cut
slides (Schott North America Inc., Elmsford, N.Y. 10523)
to avoid nanoparticle contamination from the ground
edges of traditional slides. After staining with hematoxylin
and eosin, sections were coverslipped with Permount.
After alignment of the substage oil immersion optics with
a 10× objective, sections were examined with 60× air or
100× oil immersion objectives. Enhanced darkfield
images were taken with a 2048 × 2048 pixel digital
camera (Dage-MTI Excel digital camera XLMCAT,
Michigan City, In 46360).
Statistical analysis
All analyses were performed using SAS/STAT version
9.3 for Windows. Binary outcomes of tumor incidence
(tumor or not) for each type and for the total were
analyzed using Fishers Exact test. Tumor counts were
analyzed using Poisson regression for total tumor
counts. In cases where Poisson regression demonstrated
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All analyses were stratified by promoter. Using the Proc
Lifetest procedure in SAS, the log-rank test gave a p-value
of 0.1609 for any differences among the 4 treatment
groups with respect to the survival curves. Stratifying by
initiator, the p-value with respect to the difference
between MWCNT and Air was 0.3055, and 0.1288 for the
corn oil and MC treated animals respectively.
Additional file
Additional file 1: Table S1. The table summarizes the mean exposure
concentration of MWCNT material in the inhalation chamber for each of
the animal exposure periods. The data is expressed in milligrams of
MWCNT per meter cubed as well as the total MWCNT concentration for
5hours per day for a total of 15days. The measurements of the MWCNT
material was based on data collected from Data RAM and filter samples.
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